With the MAHA movement poised to introduce a lot more "integrative" or "complementary and alternative" treatments into oncology (and medicine in general), a new study shows the likely result.
Patients who receive both standard medical treatment and complementary and alternative therapies have higher mortality — possibly due to reduced use of endocrine therapy and radiation.
The alternative medicine industry is expanding rapidly, fueled in large part by the surge of health-related content on social ...
The Food and Drug Administration has approved a new pain medication that could take the place of opioids for those experiencing moderate to severe acute pain. The drug is Journavx, or the generic name ...
One of the persistent themes we confront at SBM is the evolving double-standard in clinical medicine. On the one hand, in ...
Investigators sought to determine whether complementary and alternative medicine (CAM) affects survival in female patients with breast cancer.
As the use of injectable GLP-1 drugs continues to rise, questions persist about what happens after patients stop taking them in real-world settings. A new Cleveland Clinic analysis of nearly 8,000 ...
The study highlights that after stopping GLP-1 medications, many patients resume treatment or try alternatives, influencing weight management strategies.
SOUTH BEND, IN (WSBT) — The FDA has approved the first ever nasal medication called “Neffy” for severe allergies. It’s a new alternative to the well-known EpiPen. Severe allergic reactions are scary, ...
For the first time in two decades, the Food and Drug Administration (FDA) has approved a new class of medication that provides an alternative to addictive opioids for patients looking to manage ...